All In Biotech

Drug Trial Radar · NCT07361510

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

ROSETTA Lung-202: A Randomized, Double-Blind, Phase 3 Study of Pumitamig Monotherapy Compared to Pembrolizumab as First-line Treatment in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥ 50%.

Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 750 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

750

Planned (sponsor's estimate)

Start

Mar 12, 2026

Primary completion

Oct 14, 2031

Study completion Oct 14, 2031

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
Collaborators
BioNTech SE
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%.

Conditions

  • Non-Small Cell Lung Cancer (NSCLC)

Interventions

  • PumitamigDrug

    Specified dose on specified days

  • PembrolizumabDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free Survival (PFS) by Blinded Independent Central Review (BICR) according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1Time frame: Up to approximately 3 years
  2. Overall survival (OS)Time frame: Up to approximately 5 years

Locations

283 sites in 36 countries. Site status is shown where the registry gives one.

  • Southern Cancer Center Pc

    Daphne, Alabama · Recruiting

  • Mohtaseb Cancer Center & Blood Disorders

    Bullhead City, Arizona · Recruiting

  • Palo Verde Hematology Oncology

    Glendale, Arizona · Recruiting

  • Beverly Hills Cancer Center

    Beverly Hills, California · Recruiting

  • Orange Coast Memorial Medical Center

    Fountain Valley, California · Recruiting

  • Cancer and Blood Specialty Clinic

    Los Alamitos, California · Recruiting

  • UCLA

    Los Angeles, California · Recruiting

  • Pacific Cancer Care

    Monterey, California · Recruiting

  • Local Institution - 0403

    Oakland, California · Not yet recruiting

  • Local Institution - 0208

    Pleasant Hill, California · Not yet recruiting

  • BASS Cancer Center

    Walnut Creek, California · Recruiting

  • Local Institution - 0340

    Lakewood, Colorado · Not yet recruiting

  • Clermont Oncology Center

    Clermont, Florida · Recruiting

  • Advanced Research

    Coral Springs, Florida · Recruiting

  • BRP- Hialeah Hospital

    Hialeah, Florida · Recruiting

  • Florida Clinical Trials Group

    Tamarac, Florida · Recruiting

  • University Cancer & Blood Center, LLC

    Athens, Georgia · Recruiting

  • Local Institution - 0412

    Augusta, Georgia · Not yet recruiting

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital

    Marietta, Georgia · Recruiting

  • Local Institution - 0423

    Urbana, Illinois · Not yet recruiting

  • Northwest Cancer Centers, P.C.

    Dyer, Indiana · Recruiting

  • Missouri Cancer Associates

    Columbia, Missouri · Recruiting

  • Local Institution - 0224

    Laurelton, New York · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Recruiting

  • Optum Medical Care, PC

    Westbury, New York · Recruiting

  • Novant Health Pharmacy Oncology Specialists

    Winston-Salem, North Carolina · Recruiting

  • Cincinnati Veterans Affairs Medical Center

    Cincinnati, Ohio · Recruiting

  • Local Institution - 0418

    Oklahoma City, Oklahoma · Not yet recruiting

  • Lancaster General Hospital

    Lancaster, Pennsylvania · Recruiting

  • Local Institution - 0028

    Pittsburgh, Pennsylvania · Not yet recruiting

  • WellSpan Oncology Research

    York, Pennsylvania · Recruiting

  • University Of Texas Medical Branch At Galveston

    Galveston, Texas · Recruiting

  • Kelsey-Seybold Clinic Main Campus

    Houston, Texas · Recruiting

  • Texas Oncology - San Antonio

    San Antonio, Texas · Recruiting

  • Local Institution - 0381

    San Antonio, Texas · Not yet recruiting

  • Local Institution - 0337

    Richmond, Virginia · Not yet recruiting

  • Shenandoah Oncology, P.C.

    Winchester, Virginia · Recruiting

  • Local Institution - 0384

    Spokane, Washington · Not yet recruiting

  • Charleston Area Medical Center (CAMC)

    Charleston, West Virginia · Recruiting

  • HSHS St. Vincent Hospital Regional Cancer Center

    Green Bay, Wisconsin · Recruiting

Showing 40 of 283 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.